Background: Human immunodeficiency virus (HIV) can escape antiretroviral therapy, antibody and CD8+ T-cell pressure indicating these factors assist in viral control. The ability of CD4+ T-cells to force escape mutations and influence HIV-1 viral control remains unclear.
Methods: We applied a computational approach to identify HIV polymorphisms (adaptations) in gag, pol, and nef disproportionately associated with specific HLA-II alleles in an African cohort of chronically infected individuals. Peptides including the predicted adaptation (AE) or a non-adapted version of the epitope (NAE) were synthesized and evaluated for immunogenicity. We applied a CD8+-depleted interferon-γ ELISpot assay using PBMC obtained from chronically infected donors that were non-controllers (viral load >10,000 copies/mL), controllers (viral load <2,000 copies/mL) or acutely infected individuals. We determined the immunogenicity of predicted epitopes relative to dominant viral sequence in chronic infection, as well as transmitted founder virus (TFV) in acute HIV infection (AHI).
Results: We identified 29 HLA class-II associated HIV adaptations, all of which were demonstrated to represent novel CD4+ T-cell epitopes. Consistent with a prior study, magnitude and breadth of HIV-specific CD4+ T-cell responses seen in controllers was higher as compared to non-controllers. The magnitude of responses to epitopes containing the adapted polymorphism (AE) was lower when compared to NAE (p=0.0009). Even when the dominant viral sequence matched the predicted AE in chronic infection, NAE were more immunogenic (p=0.01). We studied a cohort of individuals with AHI to more clearly delineate the epitope responsible for observed immune responses. We found a relative lack of AE-specific CD4+ T-cell responses (p=0.008) despite the TFV encoding equal numbers of AE and NAE. Longitudinal data from AHI individuals followed for 1-2 years off antiretroviral therapy demonstrated sequence changes at predicted epitopes that were biologically confirmed to represent CD4+ T-cell mediated escape.
Conclusions: These data demonstrate the identification of HLA-II associated polymorphisms as a means to identify novel CD4+ epitopes. In addition, our studies in acute and chronic infection definitively characterize HIV escape from CD4 T-cell responses, a phenomenon that is more common than previously anticipated. Our findings emphasize the importance of inducing CD4+ T-cells along with CD8+ T-cells and antibodies as part of a comprehensive HIV vaccine strategy.